chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 1.03
Sex: M
Vaccine: MMR, PNC, VARCEL
Symptoms: Drug ineffective, Erythema, Pain, Pyrexia, Rash pruritic
Clinical narrative: Information has been received from a health professional concerning a 5 yr old white male child with no medical history, who on 10Jul01 was vaccinated IM in the left arm with the first dose of varicella virus vaccine live (Lot 638490/1900K). Concomitant vaccinations given on the same day included: the first dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (lot 638605/0252L) given IM in the right arm and the second dose of pneumococcal 4 6B 9V 14 18C 19F 23F conj vaccine (CRM197) (Prevnar) (lot479792) given in the left arm. It was unk if there was illness at the time of vaccination. On 17Dec05 the pt developed a fever and on 19Dec05 red bumps appeared. The pt continued breaking out with lesions on his belly, back and legs through 21Dec05, when the pt's mother called the office. Breakthrough chickenpox diagnosed. No lab or diagnostic tests were performed. The child stated that these both itch and hurt. Subsequently, the pt recovered from breakthrough varicella. The RN also reported that two of the pt's siblings developed adverse events following vaccine administrator (WAES numbers: 0601USA03298 and 0601USA03299). Additional information is not expected.
Age: 1.03
Sex: M
Vaccine: MMR, PNC, VARCEL
Symptoms: Rash vesicular, Skin ulcer, Viral infection
Clinical narrative: Information has been received from a health professional concerning a 5 yr old white male child with no medical history, who on 10Jul01 was vaccinated IM in the left arm with the first dose of varicella virus vaccine live (Lot 638490/1900K). Concomitant vaccinations given on the same day included: the first dose of measles virus vaccine live (Enders-Edmonston) (+) mumps virus vaccine live (Jeryl Lynn) (+) rubella virus vaccine live (Wistar RA 27/3) (lot 638605/0252L) given IM in the right arm and the second dose of pneumococcal 4 6B 9V 14 18C 19F 23F conj vaccine (CRM197) (Prevnar) (lot479792) given in the left arm. It was unk if there was illness at the time of vaccination. On 17Dec05 the pt developed a fever and on 19Dec05 red bumps appeared. The pt continued breaking out with lesions on his belly, back and legs through 21Dec05, when the pt's mother called the office. Breakthrough chickenpox diagnosed. No lab or diagnostic tests were performed. The child stated that these both itch and hurt. Subsequently, the pt recovered from breakthrough varicella. The RN also reported that two of the pt's siblings developed adverse events following vaccine administrator (WAES numbers: 0601USA03298 and 0601USA03299). Additional information is not expected.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a health professional concerning a 6 year old white male who on 10-MAY-2000 was vaccinated with a dose of varicella virus vaccine live.  On 14-Jan-2006 the patient experienced breakthrough chickenpox with less than 50 lesions and no fever.   At the time of the report the patient was recovering.  Unspecified medical attention was sought.  No product quality complaint was involved.  No other information was provided. Follow up information from a health professional indicated that the patient recovered.  The patient's sister had a similar experience after vaccination with varicella virus vaccine live (WAES 0601USA01839).  Additional information is not expected.
Age: 3.0
Sex: F
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a health professional concerning a 5-year-old white female who on 28-JAN-2003, at 3 years of age, was vaccinated with a dose of varicella virus vaccine live.  There was no concomitant therapy.  It was reported that on 07-JUL-2005, the patient developed chickenpox.  Medical attention was not sought and at the time of this report, the outcome was unknown.  Additional information has been requested.
Age: 1.0
Sex: M
Vaccine: IPV, MMR, VARCEL
Symptoms: Herpes zoster, Urticaria, Viral infection
Clinical narrative: Information has been received from a registered nurse concerning a 4-year-old male with reflux and no other pre-existing allergies, birth defects, or medical conditions who on 07-FEB-2002 was vaccinated SC in the right thigh with a first dose of varicella virus vaccine live.  Concomitant therapy that day included a first dose of measles virus vaccine live (Enders-Edmonston) + mumps virus vaccine live (Jeryl-Lynn) + rubella virus vaccine live (Wistar RA 27/3) administered SC in the left thigh and a third dose of poliovirus vaccine inactivated (Vero) administered SC in the left thigh.  The patient was noted to have hives on his chest and trunk at the time of vaccination.  On 11-JAN-2006 the patient developed herpes zoster.  There were no relevant diagnostic tests or laboratory data.  There were no adverse events following prior vaccinations.  Follow up information indicated that on the evening of 11-JAN-2006, the patient developed a low back ache and vomiting.  The patient was very weak and tired.  On 12-JAN-2006, the patient got worse.  Per the mother, the rash did progress as expected.  It was noted that the rash scabbed over, and the outcome was reported as recovered on 26-JAN-2006.  No additional information is expected.
Age: 1.01
Sex: M
Vaccine: VARCEL
Symptoms: Dermatitis bullous
Clinical narrative: Information has been received from a registered nurse concerning a 5 year old male who on April 04, 2001 was vaccinated with a dose of varicella virus vaccine live (OKA/Merck) (Lot #635454/1144K). On January 18, 2006, the patient developed a break through chickenpox-like rash with 50 lesions. Unspecified medical attention was sought. At the time of the report, the patient had not recovered. A product quality complaint was not involved. Additional information has be requested.
Age: 25.0
Sex: F
Vaccine: FLU3, VARCEL
Symptoms: Agitation, Pharyngolaryngeal pain, Pruritus
Clinical narrative: Information has been received from a registered nurse concerning a 25 year old white female with allergies to vancomycin and latex, and with Hirschsprung's disease and short-bowel syndrome who on October 30, 1995 at ; was vaccinated with a first dose of varicella virus vaccine live (Oka/Merck). There was no illness at the time of vaccination. Concomitant therapy that day included influenza virus split virion 3V vaccine inactivated (Fluzone (influenza virus split virion 3v vaccine inactivated)) (has received in the past). On October 30, 1995 at 3:40 PM, 10 minutes after injection, the patient became quite agitated and developed pain in the throat. It was noted that the patient was scratching her skin vigorously. The patient was given 0.3cc of 1:1000 dilution epinephrine. The symptoms resolved rapidly on October 30, 1995. There were no relevant diagnostic tests or laboratory data. There were no adverse events following prior vaccinations. It was also noted that the patient had a reaction to hepatitis B virus vaccine rHBsAg (yeast) (WAES #0601USA01543). No additional information is expected.
Age: 1.0
Sex: M
Vaccine: IPV, VARCEL
Symptoms: Skin ulcer
Clinical narrative: Information has been received from a health professional concerning an 8 year old white male with a history of asthma who on 21-DEC-1998 was vaccinated with a first dose of varicella virus vaccine live (Oka/Merck). Concomitant vaccine administered on the same day included a third dose of poliovirus vaccine. On 03-JAN-2006 the patient experienced 10 lesions, a few with centered blisters. The patient was treated with acyclovir and diphenhydramine hydrochloride (Benadryl). Subsequently the patient recovered. There were no laboratory or diagnostic tests performed. Additional information has been requested.
Age: 1.01
Sex: F
Vaccine: HEP, HIBV, VARCEL
Symptoms: Skin ulcer
Clinical narrative: Skin Lesion Information has been received from a health professional concerning a 9 year old white female with down's syndrome who on 27-OCT-1997 was vaccinated with a first subcutaneous dose of varicella virus vaccine live (Oka/Merck) (Lot #623556/0709E). Concomitant vaccine administered on the same day included a third intramuscular dose of Hib conj vaccine (OMPC) (MSD) (Lot #624924/1204E) and a third intramuscular dose of hepatitis B vaccine, recomb (Engerix-B) (Lot #2390A2). There was no illness at the time of vaccination. On 09-JAN-2006 the patient experienced multiple lesions on her torso, face and groin, described as possible infected. The patient was treated with cephalexin (Keflex), mupirocin (Bactroban) and symptomatic care. Subsequently the patient recovered. There were no laboratory or diagnostic tests performed. Unspecified medical attention was sought. Additional information is not expected.
Age: 1.06
Sex: M
Vaccine: DTAP, MMR, VARCEL
Symptoms: Cough, Diarrhoea, Herpes zoster, Irritability, Nasal congestion
Clinical narrative: Herpes Zoster, Cough, Pyrexia, Irritability, Diarrhea, Nasal Congestion, Pulmonary Congestion, Rhinorrhea Information has been received from a licensed practical nurse concerning a 20 month old white male with no pre-existing allergies, birth defects or medical conditions who on 12-MAY-2005 was vaccinated in the right thigh with a second dose of varicella virus vaccine live (Oka/Merck) (Lot #648942/0831P). There was no illness at the time of vaccination. No known history of varicella disease was noted. Concomitant therapy that day included a second dose of measles mumps rubella vaccine  (MSD) (Lot #648664/0992P). Other vaccinations included: the first, second, third and fourth doses of diphtheria toxoid (+) pertussis acellular 5-component vaccine (+) tetanus toxoid (Daptacel) on 23-JUN-2004 (Batch #C1698AA) left thigh, 31-AUG-2004 (Batch #C1700aA left thigh) 25-OCT-2004 (Batch #C2044AA-left thigh) and 12-MAY-2005 (Batch #C2221AA-left thigh); the first, second and third doses of poliovirus vaccine inactivated (Vero) (IPOL) on 23-JUN-2004 (Batch #X0799-right thigh) 31-AUG-2004 (Batch #X1038 left thigh) and 05-OCT-2005 (Batch #Y0425-left thigh(, the first, second, third and fourth doses of pneumococcal 4 6B 9V 14 18C 19F 23F conj vaccine (CRM197) (Prevnar) on 23-JUN-2004 (Batch #495-300 right thigh) 31-AUG-2004 (Batch #495-707 right thigh) 25-OCT-2004 (Batch #A74399K left thigh) and 05-OCT-2004 (Batch #A74406P right thigh) and the first, second, third doses of HIB conj-hepatitis B Vaccine (MSD) on 23-JUN-2004 (Lot #647480/1288N left thigh) On 07-JAN-2006 the patient presented to the office with a rash on his mid thorax area extending around towards his back. The rash was vesicular and some bad scabs. He was diagnosed with shingles. The area was itchy with approximately 30-50 lesions. Some loose stools were noted. Information received contained the following adverse events: cough (11-NOV-2005) runny nose (11-NOV-2005) nasal congestion (11-NOV-2005) fever (11-NOV-2005), increased fussiness (11-NOV-2005), chest congestion (16-DEC-2005 and cough (16-DEC2005). Additional information has been requested.
Age: 1.06
Sex: M
Vaccine: DTAP, MMR, VARCEL
Symptoms: Pulmonary congestion, Pyrexia, Rhinorrhoea, Skin ulcer
Clinical narrative: Herpes Zoster, Cough, Pyrexia, Irritability, Diarrhea, Nasal Congestion, Pulmonary Congestion, Rhinorrhea Information has been received from a licensed practical nurse concerning a 20 month old white male with no pre-existing allergies, birth defects or medical conditions who on 12-MAY-2005 was vaccinated in the right thigh with a second dose of varicella virus vaccine live (Oka/Merck) (Lot #648942/0831P). There was no illness at the time of vaccination. No known history of varicella disease was noted. Concomitant therapy that day included a second dose of measles mumps rubella vaccine  (MSD) (Lot #648664/0992P). Other vaccinations included: the first, second, third and fourth doses of diphtheria toxoid (+) pertussis acellular 5-component vaccine (+) tetanus toxoid (Daptacel) on 23-JUN-2004 (Batch #C1698AA) left thigh, 31-AUG-2004 (Batch #C1700aA left thigh) 25-OCT-2004 (Batch #C2044AA-left thigh) and 12-MAY-2005 (Batch #C2221AA-left thigh); the first, second and third doses of poliovirus vaccine inactivated (Vero) (IPOL) on 23-JUN-2004 (Batch #X0799-right thigh) 31-AUG-2004 (Batch #X1038 left thigh) and 05-OCT-2005 (Batch #Y0425-left thigh(, the first, second, third and fourth doses of pneumococcal 4 6B 9V 14 18C 19F 23F conj vaccine (CRM197) (Prevnar) on 23-JUN-2004 (Batch #495-300 right thigh) 31-AUG-2004 (Batch #495-707 right thigh) 25-OCT-2004 (Batch #A74399K left thigh) and 05-OCT-2004 (Batch #A74406P right thigh) and the first, second, third doses of HIB conj-hepatitis B Vaccine (MSD) on 23-JUN-2004 (Lot #647480/1288N left thigh) On 07-JAN-2006 the patient presented to the office with a rash on his mid thorax area extending around towards his back. The rash was vesicular and some bad scabs. He was diagnosed with shingles. The area was itchy with approximately 30-50 lesions. Some loose stools were noted. Information received contained the following adverse events: cough (11-NOV-2005) runny nose (11-NOV-2005) nasal congestion (11-NOV-2005) fever (11-NOV-2005), increased fussiness (11-NOV-2005), chest congestion (16-DEC-2005 and cough (16-DEC2005). Additional information has been requested.
Age: 4.0
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: Info has been received from a health professional concerning a 13 year old female with no pre-existing allergies, birth defects or medical conditions who on 8/16/96 was vaccinated SC with a 1st dose of varicella virus vaccine live (lot 616338/0559D). There was no illness at the time of vaccination. On 1/8/06, the pt was dx'd with varicella. At the time of the report, the pt had active disease. Additional info has been requested.
Age: 2.0
Sex: F
Vaccine: VARCEL
Symptoms: Exposure to vaccinated person, Pruritus, Pyrexia, Skin lesion
Clinical narrative: Info has been received from a mother concerning her 7 year old daughter who had an unremarkable medical history and no allergies who on 1/26/01 was vaccinated with a dose of varicella virus vaccine live (lot 535607/1153K). The pt's mother reported that on 1/17/06, her daughter had a severe breakthrough of over 400 lesions on her body. The pt was seen by her physician who prescribed ibuprofen (Motrin) and diphenhydramine (Benadryl), but no lab/diagnostic tests were performed. As of 1/20/06, the pt was noted to be slightly improved. Additional info has been requested. 05/16/2007 Information has been received from a mother concerning her 7-year-old daughter who had an unremarkable medical history and no allergies who on 26-JAN-2001 was vaccinated with the first dose of VARIVAX (Oka/Merck) (Lot #635607/1153K). There was no illness at the time of vaccination. The patient's mother reported that on 17-JAN-2006, at 0730, her daughter had a severe breakthrough of over 400 lesions on her body characterized by severe itching. The patient was afebrile. (It was noted that on 03-JAN-2006, the patient was exposed to approximately five children with chicken pox on their first day of onset of symptoms). The patient was seen by her physician who prescribed MOTRIN and BENADRYL, but no laboratory/diagnostic tests were performed. As of 20-JAN-2006, the patient was noted to be slightly improved. On 25-JAN-2006, the patient's chicken pox resolved. Additional information is not expected.
Age: 3.0
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection, Rhinorrhoea
Clinical narrative: Info has been received from an RN concerning an 11 year old white male student with asthma and a non-verbal learning disability who on 3/12/98 was vaccinated with the 1st dose of varicella virus vaccine live. There was no illness at the time of vaccination. The RN reported that on 1/11/05, the pt broke out at school with approximately 30 lesions and had a runny nose. The pt was noted to be afebrile. Medical attention was not sought and no lab/diagnostic tests were performed. On 1/17/06, the pt's lesions and runny nose resolved. Additional info has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Pyrexia, Rash
Clinical narrative: Rash; Pyrexia Information has been received from a person working in a physician's office concerning a 5 year old white female, with no medical history and no allergies who on 21-JUN-2001 was vaccinated with a first subcutaneous dose of varicella virus vaccine live (Oka/Merck). There was no illness at the time of vaccination. It was reported that a rash started on 07-JAN-2006 with 50-100 lesions on her trunk, leg, and arms. It was also reported that the patient had a slight fever. It was reported that the patient recovered on 17-JAN-2006. Medical attention was not sought. Additional information has been requested.
Age: 1.01
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: Info has been received from a health professional concerning a 7 year old white female who on 5/19/99 was vaccinated with a SC dose in the right arm of varicella virus vaccine live (lot 629613/0285J). Subsequently, the pt experienced chickenpox. It was reported that the doctor discussed symptomatic treatment with the pt's mother. Additional info has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Herpes zoster, Infection
Clinical narrative: Information has been received from a physician concerning her child who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). subsequently the patient experienced shingles. It was unknown if medical attention was sought. No product quality complaint was involved. No additional information was available. Additional information has been requested.
Age: 5.0
Sex: F
Vaccine: VARCEL
Symptoms: Varicella post vaccine
Clinical narrative: Information has been received from a consumer concerning her 5 year old daughter with no pertinent medical history and no drug reactions or allergies who in 2001 was vaccinated subcutaneously  with a 0.5mL dose of varicella virus vaccine live (Oka/Merck). There was no concomitant medication. On January 21, 2005 the patient developed a breakthrough varicella rash with about 20 lesions. There were no lab diagnostic studies performed. The outcome was reported as not covered. No medical attention was sought. There was no product quality complaint. additional information has been requested.  This is in follow-up to report (s) previously submitted on 5/12/2006.  Information has been received from a consumer concerning her 5-year-old daughter with no pertinent medical history and no drug reactions/allergies who in 2001 was vaccinated SC with a 0.5 mL dose of VARIVAX (Merck).  There was no concomitant medication.  On 21-JAN-2005 the patient developed a breakthrough varicella rash with about 20 lesions.  There were no lab diagnostic studies performed.  The outcome was reported as not recovered.  No medical attention was sought.  There was no product quality complaint.  Additional information has been received from a licensed practical nurse in response to correspondence she received related to a reported adverse event.  The nurse indicated that their records show that the consumer's 5 year old daughter, referenced in the correspondence, had not had an office visit since 2001, and therefore they were unable to complete the AE information requested.  The nurse further noted efforts to contact the family and identify their current physician were unsuccessful.  No further information is expected.
Age: 0.99
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: Information has been received from a health professional concerning an 8 year old male with no known medical history or allergies who on November 14, 1998 was vaccinated subcutaneously with a 0.5 ml dose of varicella virus vaccine live (Oka/Merck) (Lot #628149/1325H). There was no concomitant medication. The patient developed chickenpox near the end of November 2005. Unspecified medical attention was sought. Subsequently the patient fully recovered. There was no product quality complaint involved. Additional information has been request.
Age: 1.69
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: Information has been received from a physician concerning a 12 year old female patient who on July 15, 1995 was vaccinated with varicella virus vaccine live. On Jan 24, 2006 the patient experienced breakthrough varicella with less than 24 lesions on the face and torso. symptomatic care was given. Unspecified medical attention was sought but no labs were done. No product quality complaint was involved. Additional information has been requested.
Age: 6.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash vesicular, Skin ulcer
Clinical narrative: Varicella Information has been received from a registered nurse (RN) concerning a 6 year old male who on 03-JAN-2000 was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). Subsequently, on 06-JAN-2006 the patient experienced varicella. Unspecified medical attention was sought. The RN noted that the patient experienced greater than 50 varicella lesions. No outcome was reported. No product quality complaint was involved. Additional information has been requested.
Age: 1.01
Sex: F
Vaccine: HIBV, MMR, PNC, VARCEL
Symptoms: Rash vesicular
Clinical narrative: Varicella Information has been received from a health professional concerning a 12 month old white female who on 06-JAN-2006 was vaccinated with a 0.5ml subcutaneous dose in the left arm of varicella virus vaccine live (Oka/Merck) (Lot# 649992/0791R). Concomitant therapy included montelukast sodium (MSD) and budesonide (Pulmicort). Concomitant vaccine administered on same day included a first subcutaneous dose in the right arm of measles mumps rubella vaccine (MSD) (Lot # 648679/0609P) and a fourth intramuscular dose in the left thigh of Hib conj vaccine (tet toxoid) (ACTHIB) (Lot #UE767AN). Concomitant vaccine also included a fourth intramuscular dose in the right thigh of pneumococcal 4 5B 9V 14 18C 19F 23F conj vaccine (CRM197) (Prevnar) (Lot# A259694). "Late January 2006, around the 2st", the patient broke out in a chickenpox-like rash. She had been breaking out in the lesions over the course of 3 days. It was unknown how many lesions there were. At the time of the report the patient's chickenpox-like rash persisted. Unspecified medical attention was sought. No product quality complaint was involved. No there information was provided. Follow-up information from a health professional indicated that the patient had a rash since 22-JAN2--6, with red bumps all over and was fussy but negative for fever. A physical exam showed that the patient was not ill appearing, but had an erythematous papular lesions in the various stages of eruption on her face, extremities and trunk. The impression was varicella . The patient was treated with diphenhydramine hydrochloride (Benadryl), 1/2 tsp. oral administration. The patient recovered on 29-JAN-2006. Additional information is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Varicella Information has been received from a physician concerning patient (between elementary school age and high school age) who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). In approximately November 2005, "between November and December 2005" the patient experienced breakthrough chicken pox. There were 20 lesions or less. Unspecified medical attention was sought. Subsequently, the patient was fine and recovered form chicken pox. No product quality complaint was involved. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Varicella Information has been received from a physician concerning patient (between elementary school age and high school age) who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). In approximately November 2005, "between November and December 2005" the patient experienced breakthrough chickenpox. There were 20 lesions or less. Unspecified medical attention was sought. Subsequently, the patient was fine and recovered from chicken pox. No product quality complaint was involved. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Rash vesicular
Clinical narrative: Varicella Information has been received from a registered nurse concerning a school student who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). The nurse reported that her student developed break through varicella after vaccination. It was noted that all of the children in the school except one had been vaccinated (80 per grade K through 8th). The case was reported to be mild and the child did not return to school until all the pox had crusted. The child did not have the normal stages of chickenpox and the pox healed quickly. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: Info has been received from an RN concerning a school student who was vaccinated with a dose of varicella virus vaccine live. The nurse reported that her student developed break through varicella after vaccination. It was noted that all of the children in school except one had been vaccinated  (80 per grade from K through to 8th). The case was reported to be mild and the child did not return to school until all the pox had crusted. The child did not have the normal stages of chickenpox and the pox healed quickly. Additional info has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: Info has been received from a nurse concerning her daughter with no medical history who was vaccinated with a dose of varicella virus vaccine live. There was no concomitant medication. Subsequently, between 2-6 years old, she developed chicken pox. No labs were done and the pt recovered. Unspecified medical attention was sought. No product quality complaint was involved. The child's brothers had similar experiences after vaccination with varicella virus vaccine live. Additional info has been requested.
Age: 25.0
Sex: F
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Info has been received from an RN concerning a 25 year old female who in 12/05, was vaccinated with a dose of varicella virus vaccine live (lot 648298/0186F). Subsequently, the pt experienced a rash. Unspecified medical attention was sought. The pt subsequently recovered. The pt was planning to receive her 2nd dose. There was no product quality complaint involved. Additional info has been requested.
Age: 30.0
Sex: F
Vaccine: VARCEL
Symptoms: Laboratory test abnormal
Clinical narrative: Info has been received from a healthcare worker concerning a 30 year old female with no allergies or medical history, who on 6/14/05 was vaccinated, SC, with a second 0.5 mL dose of varicella virus vaccine live. Concomitant therapy included "Zelmore". In approx. 1/06, the pt had blood work performed and she found out that she was negative for immunity to varicella. Unspecified medical attention was sought. At the time of the report, the pt had not recovered. A product quality complaint was not involved. No further info is available.
Age: 1.07
Sex: M
Vaccine: VARCEL
Symptoms: Dermatitis bullous
Clinical narrative: Info has been received from a health professional concerning a 9 year old male who on 3/19/97 was vaccinated with a dose of varicella virus vaccine live (lot 620615/1340D). In 11/05, the pt presented to the office with a varicella rash. It was reported that he had less than 50 lesions and no treatment was given. No labs were done. Subsequently, the pt recovered. Unspecified medical attention was sought. No product quality complaint was involved. Additional info has been requested.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Dermatitis bullous
Clinical narrative: Info has been received from an CMA concerning a 7 year old male with no medical history or allergies who on 1/14/00 was vaccinated, SC, with a 0.5 mL dose of varicella virus vaccine live (lot 632042/1360J). There was no concomitant therapy. The CMA reported that on 1/23/06, the pt broke out in a diffuse "pox-like" rash. No fever or other symptoms were noted. Unspecified medical attention was sought, but no treatment or lab/diagnostic testing was required. At the time of this report, the pt was recovering from his "pox-like" rash. Additional info has been requested.
Age: 1.01
Sex: F
Vaccine: VARCEL
Symptoms: Dermatitis bullous
Clinical narrative: info has been received from a CMA concerning an 8 year old female with no medical history or allergies who on 7/7/98 was vaccinated, SC, with a 0.5 mL dose of varicella virus vaccine live (lot 25043/1567E). There was no concomitant therapy. The CMA reported that on 1/25/06, the pt broke out in a diffuse "pox-like" rash. No fever or other symptoms were noted. Unspecified medical attention was sought, but no treatment or lab/diagnostic testing was required. At the time of this report, the pt was recovering from her "pox-like" rash. Additional info has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: Info has been received from a health professional concerning a pt who was vaccinated, SC, with a 0.5ml dose of varicella virus vaccine live. Subsequently, the pt experienced chicken pox. Unspecified medical attention was sought. No product quality complaint was involved. Additional info has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Infection
Clinical narrative: Info has been received from a health professional concerning a pt who was vaccinated, SC, with a 0.5ml dose of varicella virus vaccine live. Subsequently, the pt experienced chicken pox. Unspecified medical attention was sought. No product quality complaint was involved. Additional info has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Infection
Clinical narrative: Information has been received from a health professional concerning a patient who was vaccinated subcutaneously with a 0.5 ml dose of varicella virus vaccine live (Oka/Merck). Subsequently the patient experienced chicken pox. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Infection
Clinical narrative: Information has been received from a health professional concerning a patient who was vaccinated subcutaneously with a 0.5 ml dose of varicella virus vaccine live (Oka/Merck). Subsequently, the patient experienced chicken pox. It was reported that the case was mild with less than 50 lesions and the child is recovering. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Infection
Clinical narrative: Information has been received from a health professional concerning a patient who was vaccinated subcutaneously with a 0.5ml dose of varicella virus vaccine live (Oka/Merck). Subsequently, the patient experienced chicken pox. It was reported that the case was mild with less than 50 lesions and the child is recovering. Unspecified medical attention was sought. No product quality complaint was involved. Additional information has been requested.
Age: 1.0
Sex: F
Vaccine: VARCEL
Symptoms: Blister, Rash macular
Clinical narrative: Information has been received from a health professional concerning an 8 year old white female who on 22 June 1998, was vaccinated in the right arm with a first dose of varicella virus vaccine live (Oka/Merck) )lot # 625047/1574E). On 18 January 2006, the patient experienced red macules and a few vesicles. Treatment included acyclovir (Zovirax) for 5 days and symptomatic care. No lab work was done, but the patient was seen in the physician's office. The patient recovered on an unknown date. Additional information is not expected.
Sex: M
Vaccine: VARCEL
Symptoms: Infection
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a male child in elementary school (who is between grades 3-5) who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). It was reported that a outbreak of chickenpox began in an elementary school in November 2005. "Recently", "since November" the male  child developed chickenpox and sought unspecified medical attention. No outcome was reported. No product quality complaint was involved. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Infection
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a child (gender not specified) in elementary school (who is between grades 3-5) who was vaccinate with a dose of varicella virus vaccine live (Oka/Merck). It was reported that an outbreak of chickenpox began in an elementary school in November 2005. "Recently", "since November 2005", the child developed chickenpox and sought unspecified medical attention. No outcome was reported. No product quality complaint was involved. Additional information has been requested.
Sex: M
Vaccine: MMR
Symptoms: Infection
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a male child in elementary school (who is between grades 3-5) who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). It was reported that an outbreak of chickenpox began in an elementary school in November 2005. "recently", "since November 2005", the male child developed chickenpox and sought unspecified medical attention. No outcome was reported. No product quality complaint was involved. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: VARCEL
Symptoms: Rash
Clinical narrative: Information has been received from a licensed practical nurse concerning a 6 year old white male with a history of cardiac murmur, who on 18 March 2003 at 14:30 PM, was vaccinated in the left arm with a first dose of varicella virus vaccine live (Oka/Merck) (lot # 643540/0604M). There was no illness at the time of vaccination. On 05 January 2006, the patient had less than 50 lesions visible for three days. No treatment was necessary and the patient had "no effects" The patient was recovered on 09 January 2006.
Sex: M
Vaccine: VARCEL
Symptoms: Infection
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a male child in elementary school (who is between grades 3-5) who was vaccinated with a dose of varicella virus vaccine live. it was reported that an outbreak of chickenpox began in an elementary school in November 2005. "Recently", "since November 2005", the male child developed chickenpox and sought unspecified medical attention. No out come was reported. No product quality complaint was involved. Additional information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Infection
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a female child in elementary school (who is between grades 3-5) who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). It was reported that an outbreak of chickenpox began in an elementary school in November 2005. "Recently", "since November 2005", the female child developed chickenpox and sought unspecified medical attention. No outcome was reported. No product quality complaint was involved.
Sex: F
Vaccine: VARCEL
Symptoms: Infection
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a female child in elementary school (who is between grades 3-5) who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). It was reported that an outbreak of chickenpox began in an elementary school in November 2005. "Recently", "since November 2005", the female child developed chickenpox and sought unspecified medical attention. No outcome was reported. No outcome was reported. No product quality complaint was involved.
Sex: U
Vaccine: VARCEL
Symptoms: Infection
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a child in elementary school (who is between grades 3-5) who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). It was reported that an outbreak of chickenpox began in an elementary school in November 2005. "Recently", "since November 2005", the child developed chickenpox and sought unspecified medical attention. No outcome was reported. No product quality complaint was involved.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Infection
Clinical narrative: Information has been received from a registered nurse concerning a 5 year old male who was vaccinated intramuscularly with a dose of varicella virus vaccine live (Oka/Merck). On 21 December 2005, the patient developed breakthrough chickenpox. Unspecified medical attention was sought. The outcome was recovering. No further information was available. There was no product quality complaint. Additional information has been requested.
Sex: M
Vaccine: VARCEL
Symptoms: Infection
Clinical narrative: Information has been received from a registered nurse (R.N.) concerning a male child in elementary school (who is between grades 3-5) who was vaccinated with a dose of varicella virus vaccine live (Oka/Merck). It was reported that an outbreak of chickenpox began in an elementary school in November 2005. "Recently", "since November 2005", the male child developed chickenpox and sought unspecified medical attention. No outcome was reported. No product quality complaint was involved.
Sex: F
Vaccine: VARCEL
Symptoms: Infection
Clinical narrative: Info has been received from a health professional concerning a female, "in grades 3-5", who was vaccinated with a dose of varicella virus vaccine live. "Recently", since November 2005, the pt experienced a chickenpox outbreak. Unspecified medical attention was sought. No other info was provided. Additional info has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Infection
Clinical narrative: Info has been received from a health professional concerning a female, "in grades 3-5", who was vaccinated with a dose of varicella virus vaccine live. "Recently", since November 2005, the pt experienced a chickenpox outbreak. Unspecified medical attention was sought. No product quality complaint was involved. No other info was provided. Additional info has been requested.
Sex: M
Vaccine: VARCEL
Symptoms: Infection
Clinical narrative: Info has been received from a health professional concerning a male, "in grades 3-5", who was vaccinated with a dose of varicella virus vaccine live. "Recently", since November 2005, the pt experienced a chickenpox outbreak. Unspecified medical attention was sought. No product quality complaint was involved. No other info was provided. Additional info has been requested.
Sex: M
Vaccine: VARCEL
Symptoms: Infection
Clinical narrative: Info has been received from a health professional concerning a male, "in grades 3-5", who was vaccinated with a dose of varicella virus vaccine live. "Recently", since November 2005, the pt experienced a chickenpox outbreak. Unspecified medical other information was provided. Additional info has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Infection
Clinical narrative: Info has been received from a health professional concerning a female "in grades 3-5", who was vaccinated with a dose of varicella virus vaccine live. "Recently", since November 2005, the pt experienced a chickenpox outbreak. Unspecified medical attention was sought. No product quality complaint was involved. No other info was provided. Additional info has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Infection
Clinical narrative: Info has been received from a health professional concerning a pt, "in grades 3-5", who was vaccinated with a dose of varicella virus vaccine live. "Recently", since November 2005, the pt experienced a chickenpox outbreak. Unspecified medical attention was sought. No product quality complaint was involved. No other info was provided. Additional info has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: Info has been received from a health professional concerning a child who was vaccinated with a dose of varicella virus vaccine live (date unspecified). Subsequently, the pt experienced breakthrough varicella. No further info was available at the time of the report. The RN also reported that the pt's siblings had adverse reactions post vaccination. Follow-up info has been received from the RN indicating that the pt's mother did not provide any additional info regarding the pt's breakthrough chickenpox. Additional info is not expected.
Sex: U
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: Info has been received from an RN concerning a child who was vaccinated with varicella virus vaccine live. Subsequently, the pt experienced breakthrough varicella. No further info was available at the time of this report. The RN also reported that the pt's siblings developed adverse experiences (WAES0601USA01871 and WAES0601USA03298). Follow-up info was received from the RN indicating that the pt's mother did not provide any additional info regarding this pt's breakthrough chickenpox. Additional info is not expected.
Sex: F
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: Info has been received from a health professional concerning a female pt who was vaccinated with a 0.5 ml dose of varicella virus vaccine live. Subsequently, the pt experienced breakthrough varicella with over 200 lesions. Unspecified medical attention was sought. No product quality complaints were involved. Additional info has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a health professional concerning a patient "in grades 3-5", who was vaccinated with a dose of varicella virus vaccine live.  "Recently", since November 2005, the patient experienced a chickenpox outbreak.  Unspecified medical attention was sought.  No product quality complaint was involved.  No other information was provided.  Addition information has been requested.
Sex: F
Vaccine: VARCEL
Symptoms: Rash, Viral infection
Clinical narrative: Information has been received from a health professional concerning a female, in grades 3-5, who was vaccinated with a dose of varicella virus vaccine live. Recently, since November 2005, the patient experienced a chickenpox outbreak. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Rash, Viral infection
Clinical narrative: Information has been received from a health professional concerning a patient, in grades 3-5, who was vaccinated with a dose of varicella virus vaccine live. Recently, since November 2005, the patient experienced a chickenpox outbreak. Unspecified medical attention was sought. No product quality complaint was involved. No other information was provided. Additional information has been requested.
Sex: M
Vaccine: VARCEL
Symptoms: Rash, Viral infection
Clinical narrative: Information has been received from a nurse concerning her son with no medical history who was vaccinated with a dose of varicella virus vaccine live. There was no concomitant medication. Subsequently, between 2-6 years he developed chicken pox. No labs were done and the patient recovered. Unspecified medical attention was sought. No product quality complaint was involved. The child's brother (WAES0601USQA03431) and sister (WAES0601USA02902) had similar experiences after vaccination with varicella virus vaccine live. Additional information has been requested.
Sex: M
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a nurse concerning her son with no medical history who was vaccinated with a dose of varicella virus vaccine live.  There was no concomitant medication.  Subsequently, between 2-6 years old he developed chicken pox.  No labs were done and the patient recovered.  Unspecified medical attention was sought.  No product quality complaint was involved.  The patient's brother (WAES 0601USA03430) and sister (WAES 0601USA02902) had similar experiences after vaccination with varicella virus vaccine live.
Sex: U
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from a infectious disease control nurse concerning a grade school age child who was vaccinated between 1999 and 2000 with a dose of varicella virus vaccine live.  In approximately November 2005 (through December 2005), the patient developed varicella.  It was unknown if medical attention was sought.  No outcome was reported.  No product quality complaints were involved.  This is one of several reports from the same source.  It was reported that there was an outbreak of varicella in a school.  Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Viral infection
Clinical narrative: Information has been received from an infectious disease control nurse concerning a grade school age child who was vaccinated between 1999 and 2000 with a dose of varicella virus vaccine live.  In approximately November 2005 (through December 2005), the patient developed varicella.  It was unknown if medical attention was sought.  No outcome was reported.  No product quality complaints were involved.  This is one of several reports form the same source.  It was reported that there was an outbreak of varicella in a school.  Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: Info has been received from an infectious disease control nurse concerning a grade school age child who was vaccinated between 1999 and 2000 with a dose of varicella virus vaccine live. In approximately 11/05 (through 12/05), the pt developed varicella. It was unknown if medical attention was sought. No outcome was reported. No product quality complaints were involved. This is one of several reports from the same source. It was reported that there was an outbreak of varicella in a school. Additional info has been requested.
Age: 5.0
Sex: M
Vaccine: VARCEL
Symptoms: Drug ineffective, Infection
Clinical narrative: Info has been received from an RN concerning a 9 year old white male who on 6/25/01 was vaccinated SC in the left arm with the 1st dose of varicella virus vaccine live (lot 638497/1905K). The RN reported that on 1/21/06, the pt developed 5-10 lesions on his trunk and 2 lesions on his face that were at various stages. The pt was seen by a physician and was treated with Benadryl and Aveeno. No laboratory/diagnostic tests were performed. In 1/06, the pt's lesions resolved. No further info is available.
Age: 1.41
Sex: F
Vaccine: VARCEL
Symptoms: Body temperature increased, Herpes zoster, Laboratory test, Pain, Rash vesicular
Clinical narrative: Information has been received from a health professional concerning a 7 yr old female with no known medical history or allergies who on 30Aug99 was vaccinated in the left thigh with a 0.5mL dose varicella virus vaccine live (lot631167/0709J). There was no concurrent medication. The pt developed herpes zoster 25Jan06. On 25Jan06 the pt had a temp of 104F. The pt was seen a day or two ago, on 28Jan06 or 29Jan06, with severe shingles. She was admitted to the hospital. The pt's herpes zoster was described as left S1-S2 distribution, plus scattered discrete vesicles (<20) on the trunk and face. The pt's pain was described as an 8, requiring morphine for 24 hrs, then acetaminophen (+) codeine phosphate (Tylenol with codeine). A specimen was taken for one of the pt's lesions, on 25Jan06 results were not reported. Subsequently, the pt recovered. The pt had no history of chickenpox. It was noted that the pt was exposed to primary varicella zoster virus from her siblings (2) when she was 3 wk of age. There was no known illness during the month following exposure. A rash did not occur at the site of injection or elsewhere within 42 days of the vaccine. There was no recent exposure to varicella or shingles. There was no product quality complaint involved. Additional information is not expected. Follow up information has been received that indicated the specimen was wild type VZV.